Skip to main content
Clinical Trials/NCT03621683
NCT03621683CompletedNot Applicable

Antioxidants vs.Ovarian Bio-stimulation Therapy to Rescue the Ovarian Reserve

Lucy Coleman2 sites in 1 country78 target enrollmentStarted: January 6, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
78
Locations
2
Primary Endpoint
variation of hormones FSH and LH directly involved with ovarian reserve

Study Overview

Brief Summary

Two group of patients were selected. Group 1 represents 46 patients that received ovarian-biostimulation monthly for three months. Group 2 represents 32 patients that received antioxidant therapy daily for 3 months. Results are noted and analysed.

Both groups represent patients with procedures already ongoing, and with diagnosed poor or depleted ovarian reserve.

The analysis has been made to compare the efficacy of both procedures.

Detailed Description

The bioestimulation group received a blood rich platelet therapy monthly for three months, with a technique developed by the laboratory. The second group of antioxidants received a combination of antioxidants monthly for three months. Both groups were compared to assess the results in terms of ovarian response (number of astral follicles, AMH levels, FSH, LH), and egg quality, embryo development, implantation rate, and successful pregnancy with healthy live birth.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
38 Years to 46 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Age between 38 and 46 years
  • FSH> 12 mIU
  • Estradiol > 100 pg/ml
  • AMH < 0.8 ng/mL

Exclusion Criteria

  • Pelvic inflammatory syndrome
  • vaginal pathologies
  • known history of hyperandrogenism
  • diagnosed platelet disorders as adhesion
  • aggregation
  • disorder of thromboxane synthesis.

Outcomes

Primary Outcomes

variation of hormones FSH and LH directly involved with ovarian reserve

Time Frame: 18 months

Both groups are compared after bio-stimulation and antioxidant therapy is performed to access any possible changes with FSH-LH post-treatment.

variation of AMH directly involved with ovarian reserve in both groups

Time Frame: 18 months

Both groups are compared after bio-stimulation and antioxidant therapy is performed to access any possible changes with AMH values.

variation in recruitment of antral follicles in both groups

Time Frame: 18 months

Both groups are compared after bio-stimulation and antioxidant therapy is performed to access any possible changes with the number of astral follicles available.

Secondary Outcomes

  • Number of good quality eggs obtained in both groups after IVF(18 months)
  • Number and quality of fertilised eggs obtained in both groups after IVF(18 months)

Investigators

Sponsor
Lucy Coleman
Sponsor Class
Industry
Responsible Party
Sponsor Investigator
Principal Investigator

Lucy Coleman

Scientific director

Fertiaguerrevere

Study Sites (2)

Loading locations...

Similar Trials